BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17067904)

  • 1. Management of vitreous loss and dropped nucleus during cataract surgery.
    Arbisser LB; Charles S; Howcroft M; Werner L
    Ophthalmol Clin North Am; 2006 Dec; 19(4):495-506. PubMed ID: 17067904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous loss during cataract surgery: prevention and optimal management.
    Jacobs PM
    Eye (Lond); 2008 Oct; 22(10):1286-9. PubMed ID: 18292788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the broken capsule.
    Wu MC; Bhandari A
    Curr Opin Ophthalmol; 2008 Jan; 19(1):36-40. PubMed ID: 18090896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation.
    Kaynak S; Celik L; Kocak N; Oner FH; Kaynak T; Cingil G
    J Cataract Refract Surg; 2006 Jan; 32(1):56-9. PubMed ID: 16516779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pars plana vitrectomy and lens management in complex vitreoretinal disease.
    Chaudhry NA; Cohen KA; Flynn HW; Murray TG
    Semin Ophthalmol; 2003 Sep; 18(3):132-41. PubMed ID: 15513474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triamcinolone-assisted vitrectomy in pediatric cataract surgery.
    Shah SK; Vasavada V; Praveen MR; Vasavada AR; Trivedi RH; Dixit NV
    J Cataract Refract Surg; 2009 Feb; 35(2):230-2. PubMed ID: 19185235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.
    Chang CJ; Chiang SY; Chen CL; Wang TY
    J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars plana vitrectomy for the management of retained lens material after cataract surgery.
    Merani R; Hunyor AP; Playfair TJ; Chang A; Gregory-Roberts J; Hunyor AB; Azar D; Cumming RG
    Am J Ophthalmol; 2007 Sep; 144(3):364-70. PubMed ID: 17632068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
    Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
    Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.
    Yamakiri K; Uchino E; Kimura K; Sakamoto T
    Am J Ophthalmol; 2004 Oct; 138(4):650-2. PubMed ID: 15488797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous management during complicated cataract surgery.
    Prasad S
    Ann Ophthalmol (Skokie); 2008; 40(3-4):123-9. PubMed ID: 19230347
    [No Abstract]   [Full Text] [Related]  

  • 13. Lensectomy-vitrectomy indications and techniques in cataract surgery.
    Sourdille P
    Curr Opin Ophthalmol; 1997 Feb; 8(1):56-9. PubMed ID: 10168275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy. The role of vitrectomy in traumatic vitreopathy.
    Coleman DJ
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(3 Pt 1):406-13. PubMed ID: 960364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cataract extraction in cases of cataract with vitreous abnormality.
    Machemer R
    Ophthalmology; 1980 Jul; 87(7):618-21. PubMed ID: 7402594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
    Dyer D; Callanan D; Bochow T; Abraham P; Lambert HM; Lee SY; Schneiderman T; Potts SL; Walker TM
    Retina; 2009 Jan; 29(1):38-45. PubMed ID: 18827733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantage of combined procedure in vitreous surgery.
    Ogino N; Kumagai K
    Semin Ophthalmol; 2001 Sep; 16(3):137-8. PubMed ID: 15513431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamcinolone-assisted vitrectomy in pediatric cataract surgery: intraoperative effectiveness and postoperative outcome.
    Praveen MR; Shah SK; Vasavada VA; Dixit NV; Vasavada AR; Garg VS; Trivedi RH
    J AAPOS; 2010 Aug; 14(4):340-4. PubMed ID: 20637663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retained posterior segment indocyanine green dye after phacoemulsification.
    Allen RC; Russell SR; Schluter ML; Oetting TA
    J Cataract Refract Surg; 2006 Feb; 32(2):357-60. PubMed ID: 16565018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
    Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
    Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.